Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foster

Showing results (1311-1320 of 1,472) with videos related to

Pageof 148
Sort By:
Open Forum Infectious Diseases|November 16, 2018
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical TrialsJason Grebely, Massimo Puoti, Heiner Wedemeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis CStefan Zeuzem, Peter Buggisch, Kosh Agarwal, et al.
Journal of Viral Hepatitis|February 28, 2026
The Impact of Hepatitis C and Socio-Demographic Variables on Health-Related Quality of Life in Pakistan: Cross-Sectional StudySiwaporn Niyomsri, Aaron G Lim, Ambreen Arif, et al.
HIV Medicine|February 27, 2016
Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaignC Orkin, S Flanagan, E Wallis, et al.
The Science of the Total Environment|March 20, 2021
COVID-19 containment on a college campus via wastewater-based epidemiology, targeted clinical testing and an interventionWalter Q Betancourt, Bradley W Schmitz, Gabriel K Innes, et al.
Plos Biology|August 26, 2020
Glycan cross-feeding supports mutualism between Fusobacterium and the vaginal microbiotaKavita Agarwal, Lloyd S Robinson, Somya Aggarwal, et al.
Hepatology (Baltimore, Md.)|January 3, 2014
Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trialZobair Younossi, Francesco Negro, Lawrence Serfaty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)H H Yoon, N R Foster, J P Meyers, et al.
Science Translational Medicine|June 14, 2019
In vivo liquid biopsy using Cytophone platform for photoacoustic detection of circulating tumor cells in patients with melanomaEkaterina I Galanzha, Yulian A Menyaev, Aayire C Yadem, et al.
Pageof 148

Showing results (1311-1320 of 1,472) with videos related to

Sort By:
Pageof 148
Open Forum Infectious Diseases|November 16, 2018
Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Virus Genotype 1 Infection Receiving Opioid Substitution Therapy: A Post Hoc Analysis of 12 Clinical TrialsJason Grebely, Massimo Puoti, Heiner Wedemeyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
Thymidylate synthase expression in colon carcinomas with microsatellite instabilityFrank A Sinicrope, Rafaela L Rego, Kevin C Halling, et al.
Hepatology (Baltimore, Md.)|October 19, 2011
The protease inhibitor, GS-9256, and non-nucleoside polymerase inhibitor tegobuvir alone, with ribavirin, or pegylated interferon plus ribavirin in hepatitis CStefan Zeuzem, Peter Buggisch, Kosh Agarwal, et al.
Journal of Viral Hepatitis|February 28, 2026
The Impact of Hepatitis C and Socio-Demographic Variables on Health-Related Quality of Life in Pakistan: Cross-Sectional StudySiwaporn Niyomsri, Aaron G Lim, Ambreen Arif, et al.
HIV Medicine|February 27, 2016
Incorporating HIV/hepatitis B virus/hepatitis C virus combined testing into routine blood tests in nine UK Emergency Departments: the "Going Viral" campaignC Orkin, S Flanagan, E Wallis, et al.
The Science of the Total Environment|March 20, 2021
COVID-19 containment on a college campus via wastewater-based epidemiology, targeted clinical testing and an interventionWalter Q Betancourt, Bradley W Schmitz, Gabriel K Innes, et al.
Plos Biology|August 26, 2020
Glycan cross-feeding supports mutualism between Fusobacterium and the vaginal microbiotaKavita Agarwal, Lloyd S Robinson, Somya Aggarwal, et al.
Hepatology (Baltimore, Md.)|January 3, 2014
Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trialZobair Younossi, Francesco Negro, Lawrence Serfaty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance)H H Yoon, N R Foster, J P Meyers, et al.
Science Translational Medicine|June 14, 2019
In vivo liquid biopsy using Cytophone platform for photoacoustic detection of circulating tumor cells in patients with melanomaEkaterina I Galanzha, Yulian A Menyaev, Aayire C Yadem, et al.
Pageof 148